RxDoctor Payments Data

John Yokitis, DO

Family Medicine · Jacksonville, FLNPI 1659361939

Payments from drug & device makers

$479in general payments, 2019–2025

Across 41 payments — averaging $11.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$229
  • AstraZeneca$75
  • Amarin Pharma, Inc.$36
  • Pfizer$34
  • Kowa Pharmaceuticals America, Inc.$25
  • Astellas Pharma US Inc$22
  • plus $57 from 4 others

What the payments were for

  • Food & beverage$479100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$479 in reported general payments places this provider in the 50th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$131,758
Medicare patients
348
Services billed
2,207

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban81$79,651
JardianceEmpagliflozin56$74,535
OzempicSemaglutide38$36,301
TrulicityDulaglutide26$31,168
MyrbetriqMirabegron34$23,159
EntrestoSacubitril/Valsartan13$21,009
FarxigaDapagliflozin Propanediol17$16,014
JanuviaSitagliptin Phosphate12$14,346
MounjaroTirzepatide12$10,208
Spiriva RespimatTiotropium Bromide11$5,575
Atorvastatin Calcium437$4,677
Gabapentin200$3,722
Celecoxib17$3,398
Rosuvastatin Calcium155$2,918
Omeprazole226$2,802

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat$16$80,10967 claims
PfizerEliquis$34$79,65181 claims
Lilly USA, LLCTrulicity, Mounjaro$12$41,37638 claims
Novo NordiskOzempic$229$36,30138 claims
Astellas Pharma US IncMyrbetriq$22$23,15934 claims
AstraZenecaFarxiga$75$16,01417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →